ClinicalTrials.govpublic full text
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
cardiovascular disease, myocardial infarction, stroke, hyperlipidemia, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 888106
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.